ZAULI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 20.051
EU - Europa 5.273
AS - Asia 3.199
SA - Sud America 32
OC - Oceania 12
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.583
Nazione #
US - Stati Uniti d'America 20.013
CN - Cina 1.771
UA - Ucraina 1.213
IT - Italia 1.185
DE - Germania 801
TR - Turchia 782
PL - Polonia 735
GB - Regno Unito 539
SG - Singapore 419
FI - Finlandia 277
SE - Svezia 262
FR - Francia 68
ID - Indonesia 64
VN - Vietnam 64
RU - Federazione Russa 57
BE - Belgio 34
CA - Canada 32
CZ - Repubblica Ceca 30
BR - Brasile 27
IN - India 24
HK - Hong Kong 23
IR - Iran 18
NL - Olanda 17
AU - Australia 12
ES - Italia 9
JP - Giappone 9
CH - Svizzera 8
IE - Irlanda 8
KR - Corea 8
RO - Romania 8
TW - Taiwan 6
MX - Messico 5
EU - Europa 4
NO - Norvegia 4
BG - Bulgaria 3
EG - Egitto 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
TZ - Tanzania 2
A1 - Anonimo 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
DZ - Algeria 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 28.583
Città #
Fairfield 3.039
Woodbridge 2.826
Houston 1.729
Ashburn 1.435
Jacksonville 1.381
Ann Arbor 1.270
Chandler 1.231
Seattle 1.183
Cambridge 1.065
Wilmington 1.057
Warsaw 724
Izmir 487
Ferrara 400
Nanjing 388
Beijing 340
Princeton 311
Singapore 254
Boardman 251
San Diego 240
Shanghai 154
New York 134
Milan 131
Shenyang 128
Nanchang 123
Dearborn 110
Los Angeles 103
Tianjin 75
Changsha 72
Hebei 70
Jiaxing 63
Dong Ket 62
Jakarta 62
Falls Church 61
Mountain View 60
Bremen 55
Jinan 52
San Mateo 50
Norwalk 48
Kunming 45
Zhengzhou 43
Auburn Hills 42
London 41
Redwood City 38
Bologna 34
Brussels 33
Tappahannock 33
Munich 31
Orange 31
Addison 23
Rome 23
Brno 22
Guangzhou 22
Philadelphia 20
Washington 20
Leawood 19
Hong Kong 18
Ningbo 18
Verona 18
Augusta 17
Des Moines 17
Ferrara di Monte Baldo 17
Helsinki 16
Indiana 16
Sanayi 16
Scottsdale 16
Trieste 16
Changchun 15
Haikou 13
Hangzhou 13
Montréal 12
Ardabil 11
Kilburn 11
Lappeenranta 11
Redmond 11
Taizhou 11
Padova 10
Lanzhou 9
San Francisco 9
Hounslow 8
Chicago 7
Genoa 7
Hefei 7
Imola 7
Monmouth Junction 7
Ottawa 7
Wuhan 7
Andover 6
Bari 6
Dallas 6
Dronten 6
Florence 6
Taipei 6
Toronto 6
Forlì 5
Frankfurt am Main 5
Fuzhou 5
Nam-gu 5
New Bedfont 5
Parma 5
Walnut 5
Totale 22.199
Nome #
Trattato di Anatomia Umana 237
Trattato di Anatomia Umana 218
Targeting mTOR in Acute Lymphoblastic Leukemia 209
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 176
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 176
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 169
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 168
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 167
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 163
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 162
Cytokine levels in the serum of healthy subjects 160
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 159
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 158
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 155
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 151
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 149
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 149
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 149
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 147
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 144
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 142
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 142
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 140
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 138
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 138
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 137
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 137
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 137
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 134
Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. 131
null 128
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 128
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 128
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 128
Antiangiogenic activity of the MDM2 antagonist nutlin-3 128
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 127
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 126
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 126
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 125
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 125
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 125
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 124
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 124
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 122
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 122
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 122
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 122
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 121
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 119
Clinical perspectives of TRAIL: Insights into central nervous system disorders 119
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 118
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 118
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 118
Association between thyroid hormones and TRAIL 118
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 118
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 117
Role of CREB transcription factor in c-fos activation in natural killer cells. 116
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 116
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 116
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 116
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 116
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 115
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 114
Cell-based therapies for diabetic complications. 114
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 114
Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors—implications for therapeutic potential 114
Actively targeted nanocarriers for drug delivery to cancer cells 114
Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women 113
Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases 113
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 112
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 112
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 112
State of art and recent developments of anti-cancer strategies based on TRAIL 112
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 111
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 110
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 110
HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. 109
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 109
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 109
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 108
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 108
JCV plus Patients with Inflammatory Bowel Disease show elevated plasma levels of MIG and SCF 108
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 108
TRAIL, a New Weapon against Neointimal Hyperplasia 108
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 108
Human herpesvirus type 7 in Hodgkin's disease 107
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 107
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 106
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 106
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 106
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 106
Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid 106
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 105
null 105
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. 105
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture 104
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 104
null 104
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 104
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 103
Totale 12.761
Categoria #
all - tutte 120.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.584
Totale 121.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.840 0 0 267 1.054 528 830 690 737 624 641 278 191
2020/20215.096 342 413 213 558 430 546 262 595 177 718 526 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/2025449 257 192 0 0 0 0 0 0 0 0 0 0
Totale 29.179